Huntsville Hospital releases statement following ‘F' grade on Leapfrog Hospital Safety report
HUNTSVILLE, Ala. (WHNT) — Huntsville Hospital released a statement following a Leapfrog Hospital Safety report grade that said the hospital received an 'F.'
You can read the full statement from Huntsville Hospital below.
The Leapfrog survey is not an accurate measure of patient safety at HuntsvilleHospital. The hospital did not complete this voluntary 353-page survey, yet Leapfrogchose to publish a rating with incomplete information. This process is unfair to thethousands of dedicated clinicians working around the clock to care for the community andrespond to emergencies anytime they are called.
Huntsville Hospital is consistently ranked by US News as the second-best hospital inAlabama (https://health.usnews.com/best-hospitals/area/al). The hospital is fullyaccredited by the Joint Commission, the gold standard for hospital quality and safety,holding hospitals accountable for over 250 standards measured in person by a sevenperson survey team. Forbes considers HH one of the best employers in Alabamaand Newsweek named HH one of America's Greatest Workplaces for Women. HH'scardiac surgery programs was recognized by Healthgrades as one of America's 50 bestprograms seven years in a row. HH is a certified stroke center and accredited by theAmerican College of Surgeon's Commission on Cancer. Blue Cross and Blue Shieldrecognizes HH for distinction in cardiac care, spine surgery, bariatric surgery, andmaternity care. Every employee and physician in the HH Health System completesmandatory training in patient safety and high reliability. HH excels in most quality ratingsand scores poorly in a Leapfrog survey that it does not complete.
Huntsville Hospital takes care of the sickest patients in north Alabama and southernTennessee. Mortality ratings referenced in the Leapfrog survey fail to account for theseverity of illness managed by hospitals that accept transfers of patients needing thehighest level of care. To ensure we are providing these patients the best possible care,Huntsville Hospital dedicates significant resources to specialty specific clinical databasesincluding the Society of Thoracic Surgery, American College of Cardiology NCDR Registry,Vermont Oxford neonatology database, National Surgical Quality Improvement Program,National Trauma database, and Cancer Registry.
The perception of this matter is not lost on us. Going forward, Huntsville Hospital andMadison Hospital will add the significant resources that are required to complete a surveyof Leapfrog's scope. While we would rather have these staff members taking care ofpatients, and we recognize that Leapfrog may not be the best indicator of hospital quality,allowing an organization to suggest we do not prioritize patient safety is an afront todedicated care givers and first responders working around the clock to make Huntsville abetter place to live.
Huntsville Hospital
This statement comes after an independent, nonprofit organization, The Leapfrog Group, released its first of two yearly grade reports and both Huntsville Hospital and Madison Hospital received an F.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
'Cervical screening saved my life,' says MLA
An MLA has said it was "shocking and really terrifying" when she was diagnosed with cervical cancer in November 2023. Michelle Guy, who was 44 at the time and experienced no symptoms, said the cancer was only caught because of cervical screening. "It terrifies me to think if I was blasé about going for screenings, what that outcome could have been; how more developed things might have been when I realised that there was a problem," she said. An average of 81 women were diagnosed with cervical cancer each year between 2017 and 2021, with about 20 deaths per year, according to the Northern Ireland Cancer Registry, which hold the most recent statistics. The Alliance Party politician hopes to use her platform to encourage women to go for cervical screening. "I'm relieved to have went through that process, relieved that the screening system worked for me; that it did find that cancer, and it did find it early," she said. The mother-of-two said her diagnosis came as "a huge surprise" as her previous smear tests had always came back clear of abnormalities. But a routine smear test two years ago showed there was "something wrong" which needed further investigation. "To find myself in that position was initially unnerving," she said. "But I was realistic that most people, they go through this, everything's fine. "That's what the screening process is for, to identify things early." A couple of weeks after having a colposcopy, while sitting in her kitchen, she received a "terrifying" phone call from the hospital asking her to come in, but not to come alone. "When you hear, don't come on your own, you know there's something wrong," she said. She was told she had cervical cancer. It was caught "at an early stage", which she said was a "relief", but it still led to months of anxiety until she completed treatment. Her treatment was a hysterectomy which she had in January 2024, while still working as a councillor for Lisburn and Castlereagh Council. "We got a level of reassurance that the hysterectomy would be a cure - that was the language that my oncologist used - that they intended this to be a cure," she said. "There isn't 100% certainty until you've had the procedure and all the different tests are complete, so I was just really anxious and determined to get it over with. "You want that operation as soon as possible because nothing's getting better while you're waiting. "I was lucky that it was contained and localised in a way that going through that surgery, as dramatic and painful as that is, I was very cognizant that things might have been worse had that diagnosis not come as early as it did." Cervical screening, while not a diagnostic test, is for people without symptoms and aims to detect early changes which could go on to develop into cervical cancer if left untreated. In some cases, cancer may be found. In December 2023, Northern Ireland introduced primary HPV cervical screening, although this was after Ms Guy's diagnosis. It checks for an infection called human papillomavirus (HPV) - the cause of most cervical cancers. This newer HPV test is regarded as a better indicator than cytology of identifying who is a higher risk of developing cervical cancer. Through her diagnosis and treatment she continued to work in politics because, not only did she feel it was "vocational", it was also a "distraction". She said she had that "reflex to stay busy" and "wanted to get as far away from what I had been through as quickly as possible". "It's that sense of I was running away from it as opposed to necessarily processing it," she added. She said she also threw herself into experiences that she may not otherwise have done so, including replacing Sorcha Eastwood as the MLA for Lagan Valley just eight months after her diagnosis. Michelle understands that there is a lack of confidence around cervical screening, particularly after what happened in the Southern Trust when 17,500 women had to have their smear tests re-checked. "Of course [that] would shake anybody's confidence in our system here - that women were going forward for their smears, and they were being let down," she said. While she had kept her cervical cancer diagnosis private, she feels now is the right time to share her experience to "hopefully do some good" and encourage women to attend screenings. "Not going for it and then potentially facing a diagnosis that I had and potentially one that's much more serious - that you knew you might have been able to prevent had you taken the opportunity of a screening - I really feel that that is a message that I didn't want to shy away from anymore," she said. New cervical cancer infection screening launched 17,500 cervical smear tests to be re-checked
Qatar Living
04-06-2025
- Qatar Living
HH The Amir sends condolences to Indian President, Prime Minister
HH The Amir Sheikh Tamim bin Hamad Al Thani sent cables of condolences on Wednesday to Indian President Droupadi Murmu, and Prime Minister Narendra Modi, on the victims of the floods that swept through several northeastern states of the country. He wished the injured a speedy recovery. At least 34 people were killed in India's northeastern region after heavy floods caused landslides over the last four days, authorities and media said, with the weather department predicting more heavy rain. More than a thousand tourists trapped in the Himalayan state of Sikkim were evacuated. Army rescue teams were pressed into action in Meghalaya state to rescue more than 500 people stranded in flooded areas. In neighbouring Bangladesh, at least four members of a family were killed in a landslide in the northeastern district of Sylhet, while hundreds of shelters have been opened across the hilly districts of Rangamati, Bandarban, and Khagrachhari. Authorities have warned of further landslides and flash floods, urging residents in vulnerable areas to remain alert. India's northeast and Bangladesh are prone to torrential rains that set off deadly landslides and flash floods, affecting millions of people every year. Roads and houses in Assam's Silchar city were flooded, visuals from news agency ANI showed, and fallen trees littered the roads. 'We're facing a lot of challenges. I've a child, their bed is submerged in water. What will we do in such a situation? We keep ourselves awake throughout the night,' Sonu Devi, a resident of Silchar, said. --- Make sure to check out our social media to keep track of the latest content. Instagram - @qatarliving X - @qatarliving Facebook - Qatar Living YouTube - qatarlivingofficial
Yahoo
02-06-2025
- Yahoo
ASCO 2025: Harbinger Health reports clinical data of blood-based MCED test
Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, US, highlighting the performance of its blood-based multi-cancer early detection (MCED) test. The test, which employs circulating tumour DNA (ctDNA) methylation patterns, shows promise in detecting various high-incidence cancers, especially in populations at elevated risk due to obesity. It is designed to fill the void in early detection for cancers that lack established screening programmes. Harbinger-developed platform integrates insights of the origin of cancer biology with AI and analytical methods to offer diagnostic and screening tools for diverse clinical settings and cancer types. The reflex test system of the company uses a two-tiered approach. The initial methylome profiling test is said to be optimised for high sensitivity to exclude disease, followed by a confirmatory reflex test with a broader methylation panel to enhance positive predictive value (PPV), rule the cancer presence and detect the tissue of origin. The Cancer ORigin Epigenetics-Harbinger Health (CORE-HH) trial, conducted in collaboration with Sarah Cannon Research Institute, enrolled around 8,095 participants from 126 US sites. It included patients diagnosed with various tumour types and a control group without suspected cancer during the enrolment period. The controls were monitored for one year to verify their cancer-free status. Key findings presented include a focus on a test cohort of 762 obese subjects, who were assembled from CORE-HH. The assessment of the test's performance was made across a range of cancer types. At 98.3% specificity, the reflex test showed a sensitivity of 25.8% for early-stage (I-II) cancers and 80.3% for advanced stages (III-IV). For cancers without current screening options, the sensitivity was 50.9%. The colorectal, breast, prostate, cervix, and lung cancer screening programmes for the general population were excluded. The company noted that in a modelled cohort of 100,000 individuals, the test detected 51 of 86 pancreaticobiliary cancers, including eight at an early stage. Harbinger Health chief medical officer Hutan Ashrafian said: 'While the obesity-associated subset demonstrates our ability to target high-risk groups, the broader results underscore the platform's potential across a wide range of deadly cancers that lack mechanisms for effective, large-scale early detection via routine screening.' In 2023, Harbinger Health raised $140m in a Series B funding round for the completion of the CORE-HH study. "ASCO 2025: Harbinger Health reports clinical data of blood-based MCED test" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
